Login / Signup

Three-Year Safety and Efficacy of the INCRAFT Endograft for Treatment of Abdominal Aortic Aneurysms: Results of the INSIGHT Study.

Giovanni Battista TorselloBertoglio LucaRichard KellersmannJan J WeverHans van OverhagenKonstantinos Stavroulakis
Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
Low-profile endografts have broadened the spectrum of patients with anatomic suitability for endovascular repair of abdominal aortic aneurysms (AAA). However, questions remain regarding the durability of the repair. The INSIGHT study evaluated the use of the INCRAFT System in routine real-world clinical practice, including patients with complex anatomies. The treatment was safe and effective. The results showed sustained clinical success over 3 years, with no aneurysm-related deaths or ruptures, and a high rate of intervention-free survival at 3 years. Despite the low-profile design of the endograft, the midterm results demonstrate the durability of AAA repair using the INCRAFT System.ClinicalTrials.gov Identifier: NCT02477111.
Keyphrases
  • abdominal aortic
  • clinical practice
  • free survival
  • randomized controlled trial
  • coronary artery
  • combination therapy
  • replacement therapy
  • drug induced